Company profile
Yomi Pharma company profile
Yomi Pharma is a biotech company that focuses on developing innovative therapeutic solutions for oncology, specifically targeting lung adenocarcinoma resistant to current treatments. Their lead candidate, YomiPep, is a "first-in-class" patented anti-EGFR peptide that works at the gene transcription level to inhibit the EGFR receptor, including rare mutations, offering a novel mechanism of action to overcome resistance to tyrosine kinase inhibitors.
Business identity
- Operating status
- Active
- Employee range
- 1-10 employees
- Founded
- 2023-01-01, Year
Headquarters
- Headquarters
- Limoges, Nouvelle-Aquitaine, France
- Postal code
- 87069
- Country code
- FR
- Continent
- Europe